- Home
- SKYX vs TCRX Comparison
SKYX vs TCRX Comparison
Compare SKYX & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYX
- TCRX
- Stock Information
- Founded
- SKYX 2004
- TCRX 2018
- Country
- SKYX United States
- TCRX United States
- Employees
- SKYX N/A
- TCRX N/A
- Industry
- SKYX Building Products
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- SKYX Consumer Discretionary
- TCRX Health Care
- Exchange
- SKYX Nasdaq
- TCRX Nasdaq
- Market Cap
- SKYX 121.0M
- TCRX 98.5M
- IPO Year
- SKYX 2022
- TCRX 2021
- Fundamental
- Price
- SKYX $1.08
- TCRX $1.21
- Analyst Decision
- SKYX Strong Buy
- TCRX Strong Buy
- Analyst Count
- SKYX 3
- TCRX 6
- Target Price
- SKYX $4.00
- TCRX $9.83
- AVG Volume (30 Days)
- SKYX 426.8K
- TCRX 473.8K
- Earning Date
- SKYX 05-13-2025
- TCRX 03-05-2025
- Dividend Yield
- SKYX N/A
- TCRX N/A
- EPS Growth
- SKYX N/A
- TCRX N/A
- EPS
- SKYX N/A
- TCRX N/A
- Revenue
- SKYX $86,276,876.00
- TCRX $2,816,000.00
- Revenue This Year
- SKYX $28.10
- TCRX $32.21
- Revenue Next Year
- SKYX $24.57
- TCRX $118.35
- P/E Ratio
- SKYX N/A
- TCRX N/A
- Revenue Growth
- SKYX 46.77
- TCRX N/A
- 52 Week Low
- SKYX $0.72
- TCRX $1.20
- 52 Week High
- SKYX $2.14
- TCRX $9.69
- Technical
- Relative Strength Index (RSI)
- SKYX 36.97
- TCRX 26.32
- Support Level
- SKYX $1.15
- TCRX $1.44
- Resistance Level
- SKYX $1.23
- TCRX $1.46
- Average True Range (ATR)
- SKYX 0.12
- TCRX 0.17
- MACD
- SKYX -0.00
- TCRX -0.02
- Stochastic Oscillator
- SKYX 7.50
- TCRX 1.79
About SKYX SKYX Platforms Corp.
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. The company's technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post and is capable of feeding electric power to an appliance. The Company generates its income from the United States.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.